A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer

Nature Genetics

Volumn 31, Issue 2, 2002, Pages 141-149

  Suzuki, Hiromu ^a   Gabrielson, Edward ^a,b   Chen, Wei ^a,b   Anbazhagan, Ramaswamy ^a,b   Van Engeland, Manon ^a,c   Weijenberg, Matty P ^c   Herman, James G ^a   Baylin, Stephen B ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE;

ARTICLE; COLORECTAL CANCER; CPG ISLAND; DEMETHYLATION; ENZYME INHIBITION; GENE CONTROL; GENE FUNCTION; GENE SILENCING; GENETIC HETEROGENEITY; GENETIC SCREENING; HUMAN; HUMAN CELL; MULTIGENE FAMILY; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR UPREGULATION; TUMOR SUPPRESSOR GENE;

COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE DEACETYLASES; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; UP-REGULATION;

EID: 0036613250     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng892     Document Type: Article

References (41)

1. DNA hypermethylation in tumorigenesis: Epigenetics joins genetics
2. p53 activates expression of HIC- 1, a new candidate tumour suppressor gene on 17p13.3
3. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification
4. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns
5. Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR
6. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer
7. Aberrant methylation of the cyclooxygenase 2 CpG island in colorectal tumors
8. CpG islands in vertebrate genomes
9. COBRA a sensitive and quantitative DNA methylation assay
10. Methylation-specific PCR a novel PCR assay for methylation status of CpG islands
11. Deletions of a differentially methylated CpG island at the SNRPN gene define a putative imprinting control region
12. SARPs: A family of secreted apoptosis-related proteins
13. A gene hypermethylation profile of human cancer
14. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
15. DNMT1 binds HDAC2 and a new co-repressor, DMAP 1, to form a complex at replication foci
16. Dnmt 3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin
17. DNA methyltransferase Dnmt 1 associates with histone deacetylase activity
18. Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription
19. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters
20. Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies
21. Loss of annexin II heavy and light chains in prostate cancer and its precursors
22. CpG island methylator phenotype in colorectal cancer
23. Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action
24. Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZ8) and fibroblast growth factor receptor 1 (FGFR1) as candidate breast cancer genes
25. WNT pathway and mammary carcinogenesis: Loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type
26. Identification of a 428-kb homozygously deleted region disrupting the SEZ 6L gene at 22q12.1 in a lung cancer cell line
27. Isolation and characterization of a human homologue of the latrophilin gene from a region of 1p31.1 implicated in breast cancer
28. Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers
29. Primary structure of human, chicken, and Xenopus laevis p11, a cellular ligand of the Src-kinase substrate, annexin II
30. A low-copy repeat in Xq26 represents a novel putatively prenylated protein gene (CXX1) and its pseudogenes (DXS9914, DXS9915, and DXS9916)
31. Imprinting in Prader-Willi and Angelman syndromes
32. Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma
33. Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population
34. Characterization and glutamyl preferring carboxypeptidase function of prostate specific membrane antigen: A novel folate hydrolase
35. Characterization of two novel protocadherins (PCDH8 and PCDH9) localized on human chromosome 13 and mouse chromosome 14
36. A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors
37. Cloning and characterization of a secreted frizzled-related protein that is expressed by the retinal pigment epithelium
38. Differential expression of frpHE: A novel human stromal protein of the secreted frizzled gene family, during the endometrial cycle and malignancy
39. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC
40. Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3β
41. Where is APC going?